BM BRIGHT MINDS BIOSCIENCES INC. Stock: price and management transactions · United States · SEC (Form 4)Source id SEC:bright-minds-biosciences-inc-7c306a US · SEC (Form 4) Mcap US$824.6M Follow the BRIGHT MINDS BIOSCIENCES INC. share price and the full management transaction log of the company, a listed issuer based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €824.6m. The latest transaction was disclosed on 19 June 2026 (10 - Acquisition or disposition in the public market). Among the most active insiders: Bottler, Nils. All data is openly available.
Analyst consensus: bullish or bearish? Analysts rate BRIGHT MINDS BIOSCIENCES INC. Strong Buy (bullish), based on 3 analysts. Average price target: US$169.80.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 19 June 2026
All Executives23 Thresholds0 Prospectus0 Other0
Declarations 23 total
▲ 3 - 10% Security Holder of Issuer · Executives · 28 Apr 2026
109,331 shares @ CA$89.50 1.05% mcap 100.0% of flow Common Shares SEDI:4738110 Canonical exit: 27 Jul 2026 (T+90) ◇ 5 - Senior Officer of Issuer · Executives · 28 May 2026
35,000 shares @ CA$1.85 0.0062% mcap 33.5% of flow Common Shares SEDI:4736418 ◇ 5 - Senior Officer of Issuer · Executives · 28 May 2026
5,000 shares @ CA$1.65 0.0008% mcap 4.3% of flow Common Shares SEDI:4736417 ◇ 5 - Senior Officer of Issuer · Executives · 28 May 2026
4,500 shares @ CA$5.24 0.0023% mcap 12.2% of flow Common Shares SEDI:4736416 ◇ 5 - Senior Officer of Issuer · Executives · 28 May 2026
35,000 shares @ CA$1.85 0.0069% mcap 33.5% of flow Options SEDI:4736415 ◇ 5 - Senior Officer of Issuer · Executives · 28 May 2026
5,000 shares @ CA$1.65 0.0009% mcap 4.3% of flow Options SEDI:4736414 ◇ 5 - Senior Officer of Issuer · Executives · 28 May 2026
4,500 shares @ CA$5.24 0.0025% mcap 12.2% of flow Options SEDI:4736412 ◇ 4 - Director of Issuer · Executives · 25 May 2026
20,000 shares Options SEDI:4735545 ● 4 - Director of Issuer · Executives · 31 Mar 2026
◇ 5 - Senior Officer of Issuer · Executives · 25 May 2026
30,000 shares Options SEDI:4735519 ◇ 5 - Senior Officer of Issuer · Executives · 26 Feb 2025
100,000 shares Options SEDI:4735515 ● 5 - Senior Officer of Issuer · Executives · 10 Feb 2025
▲ 4 - Director of Issuer, 5 - Senior Officer of Issuer · Executives · 12 Jun 2026
1,625 shares @ CA$61.081 0.010% mcap 100.0% of flow Common Shares SEDI:4735012 Canonical exit: 10 Sept 2026 (T+90) ▲ 4 - Director of Issuer · Executives · 1 Jun 2026
5,000 shares @ CA$1.84 0.0009% mcap 2.0% of flow Common Shares SEDI:4733419 Canonical exit: 30 Aug 2026 (T+90) ▲ 4 - Director of Issuer · Executives · 1 Jun 2026
2,500 shares @ CA$1.65 0.0004% mcap 0.9% of flow Common Shares SEDI:4733417 Canonical exit: 30 Aug 2026 (T+90) ◇ 4 - Director of Issuer · Executives · 3 Jun 2026
2,500 shares @ CA$1.65 0.0003% mcap 0.9% of flow Common Shares SEDI:4732666 ◇ 4 - Director of Issuer · Executives · 3 Jun 2026
5,000 shares @ CA$1.84 0.0008% mcap 2.1% of flow Common Shares SEDI:4732634 ◇ 4 - Director of Issuer · Executives · 3 Jun 2026
5,000 shares Options SEDI:4732631 ◇ 4 - Director of Issuer · Executives · 3 Jun 2026
2,500 shares Options SEDI:4732630 ▲ 4 - Director of Issuer · Executives · 1 Jun 2026
5,000 shares @ CA$85.17 0.036% mcap 97.0% of flow Common Shares SEDI:4732622 Canonical exit: 30 Aug 2026 (T+90) 109,331 shares @ US$89.50 1.44% mcap 64.1% of flow Common Shares SEC:0000929638-26-001708:0
184,331 shares @ US$21.70 78.8% of flow Common Shares SEC:0000929638-24-003752:0
Canonical exit: 2 Feb 2025 (T+90) 238,097 shares @ US$4.5304 21.2% of flow Common Shares SEC:0000929638-24-003542:0
Canonical exit: 13 Jan 2025 (T+90) About BRIGHT MINDS BIOSCIENCES INC. Bright Minds Biosciences Inc. is a company focused on developing innovative treatments for psychiatric disorders. It is listed on the NASDAQ.